Insmed
INSM
#542
Rank
C$60.73 B
Marketcap
C$284.78
Share price
-0.51%
Change (1 day)
169.61%
Change (1 year)

Revenue for Insmed (INSM)

Revenue in 2025 (TTM): C$0.62 Billion

According to Insmed's latest financial reports the company's current revenue (TTM ) is C$0.62 Billion. In 2024 the company made a revenue of C$0.52 Billion an increase over the revenue in the year 2023 that were of C$0.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insmed from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$0.62 B20.29%
2024 C$0.52 B28.93%
2023 C$0.40 B21.59%
2022 C$0.33 B38.62%
2021 C$0.24 B14.57%
2020 C$0.20 B17.62%
2019 C$0.17 B1230.38%
2018 C$13.39 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 C$12.24 M
2012 N/A-100%
2011 C$4.49 M-35.06%
2010 C$6.91 M-36.61%
2009 C$10.91 M-24.54%
2008 C$14.46 M94%
2007 C$7.45 M545.47%
2006 C$1.15 M657.28%
2005 C$0.15 M-7.31%
2004 C$0.16 M-15.43%
2003 C$0.19 M-93.7%
2002 C$3.08 M554.81%
2001 C$0.47 M-1224.07%
2000 -C$0.05 Million

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
C$3.36 B 439.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$78.69 B 12,510.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$40.60 B 6,406.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$1.86 B 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.29 B-52.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$16.36 B 2,522.53%๐Ÿ‡บ๐Ÿ‡ธ USA